Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Defense Advanced Research Projects Agency

Defense Advanced Research Projects Agency

Defense Advanced Research Projects Agency is a venture capital firm and the central research and development organization for the US Department of Defense focusing on companies within the artificial Intelligence, information technology, and national security sectors

DARPA is a venture capital firm and is the central research and development organization for the US Department of Defense. Headquartered in Arlington, Virginia, United States, it focuses on companies within the artificial Intelligence, information technology, and national security sectors. It usually issues funds for grants and Series A Rounds. Its portfolio companies include GRYFN, Xanadu, Cogito Corporation, Voyant Photonics, Ayar Labs, Worcester Polytechnic Institute, Vector Launch, Paradromics, Synchron and Gamalon.

The Defense Advanced Research Projects Agency lists their mission as making pivotal investments in breakthrough technologies for national security. As part of this, they work to find transformational change instead of incremental advances. They work with academic, corporate and governmental partners with a focus on the United States military services.

DARPA comprises approximately 220 government employees in six technical offices, including near 100 program managers overseeing 250 research and development programs.

Known before as the Advanced Research Projects Agency (ARPA), the agency was created in February 1958 by President Dwight D. Eisenhower in response to the Soviet launching of Sputnik 1 in 1957.

As of 2020, Dr. Victoria Coleman serves as the 22nd director of the Defense Advanced Research Projects Agency, the highest office in the department.

Timeline

1958
Founded

Invested in

Funding Rounds Participated In

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
William Harwood
June 30, 2021
news.yahoo.com
SpaceX Transporter 2 mission highlights growing market for small satellite launches.
INOVIO Pharmaceuticals, Inc.
April 27, 2021
www.prnewswire.com:443
/PRNewswire/ -- INOVIO (NASDAQ: INO) announced today that first quarter 2021 financial results will be released after the market close on May 10, 2021....
April 15, 2021
BioSpace
INOVIO's COVID-19 Vaccine Candidate, INO-4800, Provides Broad Cross-reactive Immune Responses In Humans Against Variants of Concern - read this article along with other careers information, tips and advice on BioSpace
March 2, 2021
WebWire
, , , , • Mobile platform intended to produce -1,000s of ready-to-use doses at the site of need in under 3 days , , • Project leverages GE's expertise regarding synthetic method for producing industrial amounts of DNA , , • GE's DNA-based approach could be compatible with new, recently approved RNA-based COVID-19 vaccines , , , , , , Aiming to enable vaccine production on-demand, anywhere in the world in just days, GE Research and a multi-disciplinary team that includes the Broad Institute,...
INOVIO Pharmaceuticals, Inc.
February 24, 2021
www.prnewswire.com:443
/PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an extension of their partnership...
SHOW MORE

References

Golden logo
By using this site, you agree to our Terms & Conditions.